Created on the initiative of Ekkio Capital in 2007-2008, Novescia is a medical biology group with an industrial project in partnership with healthcare professionals. Built around successive acquisitions, the group of laboratories completed the acquisition of Générale de Santé's medical biology division in 2010, to diversify its activities into analyses for clinics. When it was sold to Cerba European Lab in 2014, Novescia was operating around 100 laboratories and generating a turnover of €150 million.
Investment date: 2009
Exit date: 2014
